GENERAL CONCLUSIONS AFTER THE ADMINISTRATION OF HUMANOFORT

Parameter

Sex

Principal variation

Mean

Regulatory effect

Total cholesterol

Men

Women

100% decrease

100% decrease

32.3 mg

29.5 mg

22% decrease       50 mg

23% decrease       50 mg

LDL cholesterol

Men

Women

89% decrease

100% decrease

39 mg

34 mg

11% increase in subjects with low initial values 10% decrease  40 mg

Risk factors TC/HDL

Men

Women

100% decrease (moderate, low)

82% decrease

23% decrease had highest risk, all reduced to moderate

0.84

1.01

4 cases with initial high risk were reduced to one

30% presented a slight increase or non-receptive

Apo B/A

Men

Women

70% decrease

60% decrease

0.80

0.75

30% regulatory increase

40% regulatory increase

Insulin

Men

Women

82% decrease

45% decrease

55% decrease

5.18 uU

4.44 uU

4.33 uU

In 4 cases the decrease was higher than 17 uU

Regulatory variations within physiological range

IGF

Men

Women

77% decrease (29% high values)

75% decrease (24% high values)

77 ng

80 ng

The increases were within physiological range

The administration of Humanofort induced a clear-cut variation of parameters investigated towards the physiological range. Generally, as the initial values were higher, the regulatory variations were also higher or mostly decrease. Therefore, the regulatory effect of Humanofort was function of the initial values parameters. The same effect was also noticed with other parameters investigated, but not presented above, such as triglycerides, Cortisol, 17 ketosteroids, as well as some immunological: CEA, PSA and CRP (Protein C Reactive).

The interpretation of this study was performed by :

Dr. Radu OLINESCU, Ph.D. Senior Scientist from the Clinical Hospital Fundeni, Department of Biochemistry, Bucharest and former Visiting Professor at Department of Nutrition, University of Illinois at Urbana-Champaign, USA.